Family · Pharmaceutical analytical standards
Oxacillin
A semisynthetic penicillin resistant to penicillinase, the enzyme many staphylococci use to destroy penicillin; patented in 1960 and approved in 1962, it is used against infections caused by penicillin-resistant Staphylococcus aureus. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?Resistant staphylococci are called MRSA after methicillin, but laboratories have long used oxacillin to identify them, so they are also known as ORSA; unlike methicillin, it could also be taken by mouth.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
